Skip to main content
. 2016 Jan 25;11(1):e0147411. doi: 10.1371/journal.pone.0147411

Fig 5. Model of ChREBP-induced lipid accumulation in β-cells.

Fig 5

Plus symbol, upregulation; Minus symbol, downregulation; Pgk1, phosphoglycerate kinase1; Eno1, enolase1; Pklr, L-type pyruvate kinase; Mdh1, malate dehydrogenase 1; Me1, malic enzyme1; Pdha1, pyruvate dehydrogenase (lipoamide) alpha 1; Cs, citrate synthase; Acly, ATP citrate lyase; Mid1ip1, MID1 interacting protein 1; Acaca, acetyl-CoA carboxylase alpha; Fasn, fatty acid synthase; Elovl6, ELOVL fatty acid elongase 6; Rgs16, regulator of G-protein signaling 16; Cpt1a, carnitine palmitoyltransferase 1; G-6-P, glucose-6-phosphate; G-3-P, glyceraldehydes-3-phosphate; 1,3-BPG, 1,3-bisphosphoglycerate; 3-PGA, 3-phosphoglycerate; 2-PGA, 2-phosphoglycerate; PEP, phosphoenolpyruvate; Pyr, pyruvate; DHAP, dihydroxyacetone phosphate; Glycerol-3-P, glycerol;-3-phosphate; OAA, oxaloacetate.